Relafen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2004
02419872004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND Dietary compounds or nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce cancer rates. Elevation of phase II… (More)
Is this relevant?
2002
2002
BACKGROUND Pseudoporphyria is a diagnosis that is used when porphyria-like clinical lesions arise in the setting of normal… (More)
Is this relevant?
2000
2000
A double-blind, placebo-controlled clinical trial comparing the effect on hemostasis of nabumetone (Relafen) to placebo in… (More)
Is this relevant?
1999
1999
Various oral medications including nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with pseudoporphyria… (More)
Is this relevant?
Review
1999
Review
1999
New information indicates that cyclooxygenase-2 (COX-2) is constitutively expressed in several tissues, including brain, lung… (More)
Is this relevant?
1998
1998
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been claimed to reduce cancer rates in oesophagus, stomach and colon of humans… (More)
Is this relevant?
1998
1998
Several dietary compounds have been demonstrated to reduce gastrointestinal cancer rates in both humans and animals. We showed… (More)
Is this relevant?
Review
1994
Review
1994
It is now that there are two isozymes of prostaglandin endoperoxide (PGH) synthase (cyclooxygenase) called PGH synthase-1 and -2… (More)
Is this relevant?
Review
1992
Review
1992
Fifteen nonsteroidal anti-inflammatory drugs (NSAIDs) are available in the United States today, yet no clear distinctions among… (More)
Is this relevant?
1987
1987
Forty-seven patients with active rheumatoid arthritis were entered into a single-blind study to compare the safety and efficacy… (More)
Is this relevant?